Lamonica, D <br/><br/>
Radioimmunoscintigraphy (RIS) with bectumomab (Tc99m labeled IMMU-LL2, Lymphoscan) in the assessment of recurrent non-Hodgkin's lymphoma (NHL).  [electronic resource] 

 -  Cancer biotherapy & radiopharmaceuticals  Dec 2002 
 - 689-97 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1084-9785 
<br/><br/><label>Standard No.: </label>10.1089/108497802320970307  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal<br/>Humans<br/>Lymphoma, B-Cell--diagnostic imaging<br/>Magnetic Resonance Imaging<br/>Radioimmunodetection<br/>Recurrence<br/>Tomography, Emission-Computed, Single-Photon<br/>Tomography, X-Ray Computed